Skip to content
中文产业新闻评分70Chinese source

大睿生物 ALK7 RNAi 减重候选药独家授权罗氏，总额超 77 亿元

总金额超77亿，大睿生物差异化靶点减重RANi候选管线独家授权罗氏

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.